Table 1 Characteristics of arthritis patients
| Â | Rheumatoid arthritis (n = 12) | Spondyloarthritis (n = 24) |
|---|---|---|
Age (years) | 43 (37.8-51.2) | 37.5 (31-47.2) |
Male/female | 5/7 | 9/15 |
Disease duration (months) | 33 (4.25-114) | 7.5 (3.75-24) |
CRP (mg/l) | 39.7 (7.4-69.2) | 10.5 (2.9-32.2) |
ESR (mm/h) | 41 (21-60.7) | 25 (16.5-51) |
WBC SF (cells/μl) | 12,100 (9450-15500) | 6900 (3050-10100) |
DMARDs in use (by number of patients) | no (7), hydroxychloroquine and sulphasalazine (1), methotrexate (1), leflunomide (1), anti-TNF (2) | no (18), sulphasalazine (2), methotrexate (3), leflunomide (1) |
RF (% positive patients) | 55 | 11 |
Anti-CCP (% positive patients) | 70 | 19 |